McKay, R. R., De Velasco, G., Werner, L., Bellmunt, J., Harshman, L., Sweeney, C., . . . Choueiri, T. K. (2016). A phase I study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor targeted therapies. Cancer.
استشهاد بنمط شيكاغوMcKay, Rana R., et al. "A Phase I Study of Buparlisib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma Progressing On Vascular Endothelial Growth Factor Targeted Therapies." Cancer 2016.
MLA استشهادMcKay, Rana R., et al. "A Phase I Study of Buparlisib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma Progressing On Vascular Endothelial Growth Factor Targeted Therapies." Cancer 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.